EMORY UNIVERSITY

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 1836-12-10

Employees: 10K

Market Cap: -

Website: http://www.emory.edu

Clinical Trials

Transfusion of Biotinylated Red Blood Cells

Phase 1

Completed

Conditions: Anemia

Interventions: Drug: Biotin-Labeled Red Blood Cells (RBCs)

First Posted Date: 2016-05-02

Last Posted Date: 2023-05-09

Lead Sponsor: Emory University

Target Recruit Count: 5

Registration Number: NCT02757898

Locations: 🇺🇸
Emory University, Atlanta, Georgia, United States

Evaluating the Electro Magnetic Interference of Using Tablet and Smart Phone on Leadless Pacemaker (MICRA)

Not Applicable

Completed

Conditions: Bradycardia, Atrial Tachyarrhythmia

Interventions: Device: Use of a Tablet
Device: Use of a Smart Phone

First Posted Date: 2016-05-02

Last Posted Date: 2017-11-09

Lead Sponsor: Emory University

Target Recruit Count: 20

Registration Number: NCT02758210

Locations: 🇺🇸
Emory University Hospital, Atlanta, Georgia, United States
🇺🇸
Emory University Hospital Midtown, Atlanta, Georgia, United States

Physiological Augmentation of Mindfulness Meditation

Not Applicable

Completed

Conditions: Post Traumatic Stress Disorder

Interventions: Other: Breath-Focused Meditation
Device: Physiological Feedback

First Posted Date: 2016-04-28

Last Posted Date: 2022-10-17

Lead Sponsor: Emory University

Target Recruit Count: 65

Registration Number: NCT02754557

Locations: 🇺🇸
Grady Health System, Atlanta, Georgia, United States
🇺🇸
Wesley Woods Center, Atlanta, Georgia, United States

Neurologic Injury Following Aortic Arch Replacement

Not Applicable

Completed

Conditions: Hemi Arch Replacement
Aortic Arch Replacement

Interventions: Procedure: DHCA+RCP
Procedure: MHCA + SACP

First Posted Date: 2016-04-25

Last Posted Date: 2018-03-30

Lead Sponsor: Emory University

Target Recruit Count: 20

Registration Number: NCT02750423

Locations: 🇺🇸
Emory University Hospital, Atlanta, Georgia, United States
🇺🇸
Emory Saint Joseph's Hospital, Atlanta, Georgia, United States

Defining a PD-specific Breath Fingerprint of Underlying Inflammatory and Neurodegenerative Processes

Completed

Conditions: Parkinson's Disease

Interventions: Other: Blood Sample Collection
Other: Breath Sample Collection

First Posted Date: 2016-04-22

Last Posted Date: 2019-06-18

Lead Sponsor: Emory University

Target Recruit Count: 100

Registration Number: NCT02749214

Locations: 🇺🇸
The Emory Clinic Executive Park, Atlanta, Georgia, United States

Targeted Fusion Biopsy of the Prostate

Phase 2

Completed

Conditions: Prostatic Neoplasms

Interventions: Drug: FACBC PET-CT Scan
Procedure: Three-dimensional ultrasound-guided biopsy
Procedure: Standard transrectal ultrasound (TRUS) guided biopsy

First Posted Date: 2016-04-20

Last Posted Date: 2019-05-08

Lead Sponsor: Emory University

Target Recruit Count: 21

Registration Number: NCT02744534

Locations: 🇺🇸
Emory University Winship Cancer Institute, Atlanta, Georgia, United States
🇺🇸
Emory University Hospital, Atlanta, Georgia, United States

Zambia One Love Aim 3 Trial

Not Applicable

Completed

Conditions: HIV
Non-communicable Diseases
Neglected Diseases
Sexually Transmitted Diseases

Interventions: Behavioral: Good Health Package Plus (GHPP)
Behavioral: Strengthening Our Vows (SOV)

First Posted Date: 2016-04-20

Last Posted Date: 2018-02-01

Lead Sponsor: Emory University

Target Recruit Count: 3450

Registration Number: NCT02744586

Locations: 🇿🇲
Lusaka Research Site, Lusaka, Zambia
🇿🇲
Ndola Research Site, Ndola, Copperbelt, Zambia

Sitagliptin in Non-Diabetic Patients Undergoing General Surgery

Phase 4

Completed

Conditions: Hyperglycemia

Interventions: Drug: Placebo
Drug: Sitagliptin
Drug: Supplemental insulin (insulin lispro)
Drug: Supplemental insulin (insulin aspart)
Drug: Long acting basal insulin (insulin detemir)
Drug: Long acting basal insulin (insulin glargine)

First Posted Date: 2016-04-18

Last Posted Date: 2018-06-27

Lead Sponsor: Emory University

Target Recruit Count: 80

Registration Number: NCT02741687

Locations: 🇺🇸
Grady Memorial Hospital, Atlanta, Georgia, United States
🇺🇸
Emory University Hospital Midtown, Atlanta, Georgia, United States

RBC Irradiation, Anemia and Gut Injury

Conditions: Necrotizing Enterocolitis
Anemia

Interventions: Device: Near Infrared Spectroscopy

First Posted Date: 2016-04-18

Last Posted Date: 2021-04-21

Lead Sponsor: Emory University

Target Recruit Count: 220

Registration Number: NCT02741648

Locations: 🇺🇸
Grady Memorial Hospital, Atlanta, Georgia, United States
🇺🇸
Emory University Hospital Midtown, Atlanta, Georgia, United States
🇺🇸
Northside Hospital - Neonatology, Atlanta, Georgia, United States

Pioglitazone and Tyrosine Kinase Inhibitor in Treating Patients With Relapsed Chronic Myeloid Leukemia

Phase 2

Terminated

Conditions: Chronic Myelogenous Leukemia, BCR-ABL1 Positive
Recurrent Chronic Myelogenous Leukemia, BCR-ABL1 Positive

Interventions: Drug: Pioglitazone
Drug: Tyrosine Kinase Inhibitor (TKI)

First Posted Date: 2016-04-06

Last Posted Date: 2019-01-09

Lead Sponsor: Emory University

Target Recruit Count: 9

Registration Number: NCT02730195

Locations: 🇺🇸
Emory University/Winship Cancer Institute, Atlanta, Georgia, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy